1/3/2023 7:12:31 AM
ASLAN Pharma, Thermo Fisher Scientific Partner To Manufacture High Concentration Formulation Of Eblasakimab
9/14/2022 7:17:36 AM
ASLAN Pharma Begins Clinical Program To Study Eblasakimab In Dupilumab-Experienced Atopic Dermatitis Patients
8/25/2022 7:21:00 AM
ASLAN Licenses BelleStudy Digital Image Capture Software In Support Of ASLAN's Clinical Trials For Atopic Dermatitis
10/26/2021 8:01:12 AM
ASLAN Pharma Q3 Net Loss $8.6 Mln Vs Loss Of $3.5 Mln Last Year